Verisk Analytics: Priced for Perfection, Reality Is Brutal $151 vs $24
By stockpickr AI | April 6, 2026 | 10 min read
Investment Summary
Verisk Analytics provides data analytics and decision support solutions primarily to the insurance industry. Sentiment is generally positive following recent strategic moves.
Investment Recommendation
Sell
Fair Value: $24.19
Current Price: $151.18
Upside/Downside: -84.0%
No recommendation provided
Key Metrics
- Market Cap: $28.08 Billion
- P/E Ratio: 39.50
- Dividend Yield: 1.11%
- Analyst Target Price: $315.75
Strengths
- Dominant, high-margin position in the P&C insurance data and analytics sector, creating significant barriers to entry.
- Strong recurring revenue model driven by subscription services and essential workflow solutions.
- Recent strategic portfolio streamlining and focus on core insurance analytical assets.
Risk Factors
- Reliance on the performance and regulatory environment of the Property & Casualty (P&C) insurance industry.
- Increasing competition from cloud-native data providers and potential disruption from AI-driven underwriting.
- Slower growth trajectory compared to high-growth SaaS peers due to the mature nature of key markets.
Latest News
Verisk Stock Continues Modest Climb Amid Sector Rebalancing
VST shares experienced a slight upward trend over the past few trading days as investors digested broad market movements, keeping the stock within its established range.
Source: The Wall Street Journal | Sentiment: Slightly Positive
Verisk (VST) Is The Undervalued Data Goliath For Insurance Sector
A recent analysis highlights VST's deep moat in insurance analytics, suggesting that market skepticism regarding recent divestitures overlooks the core company's intrinsic value.
Source: Seeking Alpha | Sentiment: Moderately Positive
Verisk Reviews Q1 Outlook Amid Favorable Premiums
Management provided an update reaffirming full-year guidance, driven by robust data consumption activity from the property and casualty insurance sector.
Source: Yahoo Finance | Sentiment: Moderately Positive